j.sandvik
TL2 · Braga
Contributes reviews on supplier material. Based in Braga.
Joined 26 July 2025 · last posted 4d
86 posts, newest first. Showing up to 150.
-
Common supplements people ask about, assessed one at a time Replied, post #90 · Practice › Interactions · 24 Jul 2026 · 14 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
What a certificate commits its issuer to — one year on Replied, post #113 · Analytics › COA interpretation · 20 Jul 2026 · 6 likes Post #111 answers the question as asked. The question underneath it is different. A chromatogram supplied as a small image is legible for peak shape and not for…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #15 · Evidence › Preprints · 4 Jul 2026 · 0 likes I would put moderate confidence on the mainstream reading of community labels and no more. That is not scepticism for its own sake; it is where the sourcing actually…
-
What a certificate commits its issuer to — one year on Replied, post #97 · Analytics › COA interpretation · 27 Jun 2026 · 24 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #49 · Analytics › Impurities & related substances · 17 Jun 2026 · 9 likes Confirming post #46 from a second method, which matters more than confirming it from a second person. Aggregates: multiples of the monomer mass. May not elute at all…
-
Micronutrient adequacy at low total intake Replied, post #17 · Nutrition & Training › Protein & intake · 7 Jun 2026 · 14 likes If someone has run micronutrient adequacy properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Micro-titration: a disputed topic, argued properly Replied, post #84 · Practice › Dosing & titration · 4 Jun 2026 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #46 · Access › Insurance & coverage · 3 Jun 2026 · 0 likes Building on post #45 rather than restating it. Careful with the language on appeal. "Not detected" and "not present" are different findings and the first is a statement…
-
Racemisation and why it is invisible to a mass measurement — what changed since Replied, post #9 · Analytics › Impurities & related substances · 3 Jun 2026 · 18 likes Racemisation produces a diastereomer that is mass-identical and chromatographically resolvable only on a method chosen for the purpose. Standard reversed-phase…
-
CJC-1295 with and without DAC: what the modification does Replied, post #71 · Compounds › Secretagogues & GH axis · 31 May 2026 · 26 likes I had written a reply contradicting post #69 and deleted it. Here is what survived. On analysis: these are short peptides and generally straightforward…
-
Prescription requirements and telehealth models — a second dataset Replied, post #46 · Sourcing › Regulatory · 29 May 2026 · 19 likes I read post #45 twice before replying, because I had assumed the opposite. Generic or biosimilar entry depends on patent and exclusivity positions that are…
-
A checklist for reading a certificate in under two minutes Replied, post #29 · Analytics › COA interpretation · 28 May 2026 · 7 likes Everything in post #27 holds. The case it does not cover is the one I have. An itemised related-substances table with retention times says considerably more about the…
-
Reading a trial's population section before its results Replied, post #61 · Evidence › Trials · 28 May 2026 · 30 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
-
Forced degradation studies: designing one that is informative Replied, post #53 · Analytics › Method validation · 10 May 2026 · 20 likes Noted, and I have changed what I was going to do on the strength of it.
-
Why chargeback is not the safety net people assume Replied, post #12 · Sourcing › Payments · 5 May 2026 · 18 likes Chargeback is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
-
Reimbursement variation across member states Replied, post #2 · Regional › European Union · 30 Apr 2026 · 10 likes Anyone quoting an eligibility threshold should cite the national document, because thresholds differ between states and have changed within them. The part I am sure of…
-
Fasting versus non-fasting and which tests care Replied, post #20 · Clinical › Bloodwork · 29 Apr 2026 · 6 likes Coming back to post #16, because the follow-up matters more than the original answer. My understanding of fasting versus non-fasting is a few years old and may have…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #52 · Devices › Syringes & needles · 22 Apr 2026 · 27 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Reading a home test result without over-claiming Replied, post #9 · Analytics › Home & field testing · 10 Apr 2026 · 14 likes Coming back to post #7, because the follow-up matters more than the original answer. Nothing available at home distinguishes a correct sequence from a closely related…
-
Grapefruit: why this class is not the class that cares Replied, post #113 · Practice › Interactions · 3 Apr 2026 · 10 likes Two sentences on grapefruit and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred…
-
The "under review" status pill and when a moderator applies it Replied, post #50 · Evidence › Preprints · 2 Apr 2026 · 18 likes Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one. Reading it back, the…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #76 · Practice › Storage & stability · 28 Mar 2026 · 0 likes I would call the community position on Adsorptive losses likely rather than established, and I would be comfortable defending that hedge.
-
Anaesthesia and elective surgery: the aspiration question Replied, post #47 · Practice › Interactions · 11 Mar 2026 · 16 likes The arithmetic on anaesthesia and elective surgery is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #93 · Documentation › Wiki requests · 17 Feb 2026 · 15 likes This follows post #90 rather than contradicting it. Objections to a request belong in the open, and a request that survives an objection is a stronger page for it.
-
Foaming during reconstitution and whether it matters — the long version Replied, post #36 · Practice › Reconstitution · 16 Feb 2026 · 28 likes Post #33 put the caveat in the right place and I want to underline it. Adding what did not work for me on Foaming during reconstitution, since the failures never get…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #20 · Evidence › Trials · 26 Jan 2026 · 0 likes Nobody has said the unglamorous part of Reading a supplementary appendix yet, so: most of the variation is explained by things that are boring to write about and easy…
-
A history of disordered eating: proceeding carefully Replied, post #49 · Wellbeing › Mental health · 3 Jan 2026 · 22 likes Post #48 describes the usual case. This is about the unusual one. Practical answer on history of disordered eating, since the theoretical one is upthread: do the…
-
Travelling with an injectable: documentation and practicalities Replied, post #3 · Access › International · 24 Dec 2025 · 24 likes This follows the opening post rather than contradicting it. Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #26 · Sourcing › Regulatory · 22 Dec 2025 · 25 likes Adding the measurement that post #24 says would settle it. Shortage notifications are published by several regulators and are the authoritative source for a question…
-
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #3 · Compounds › Semaglutide · 16 Dec 2025 · 6 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Temperature loggers worth the money — the long version Replied, post #89 · Devices › Cold chain · 8 Dec 2025 · 14 likes Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day at room temperature is usually acceptable. Days to weeks at room…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #24 · Outcomes › Body composition · 8 Dec 2025 · 0 likes Narrowing post #23, because the general version has more than one answer. DXA (dual-energy X-ray absorptiometry): the standard for body composition in research.…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #45 · Compounds › Tirzepatide · 6 Dec 2025 · 1 like Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #11 · Meta › Site feedback · 1 Dec 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Availability by country, dated, with primary sources Replied, post #74 · Access › International · 24 Nov 2025 · 21 likes The thing about availability that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #27 · Analytics › Impurities & related substances · 19 Nov 2025 · 1 like Deletion sequences arise from incomplete coupling and are lower by one residue mass. Where they elute depends on the hydrophobicity of the residue that is missing, so…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #101 · Compounds › Tirzepatide · 18 Nov 2025 · 16 likes A note on how tirzepatide titration schedules gets discussed rather than on tirzepatide titration schedules itself: the confident posts get the replies and the careful…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #141 · Practice › Storage & stability · 15 Nov 2025 · 0 likes Picking up post #140: that is the part I would want checked first. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
-
[2026 update] What a good consultation looks like from the other side Replied, post #2 · Clinical › Prescriber conversations · 28 Oct 2025 · 13 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. The honest answer is that it…
-
Thyroid function tests during substantial weight change Replied, post #104 · Clinical › Bloodwork · 21 Oct 2025 · 29 likes Adding the measurement that post #101 says would settle it. Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #66 · Practice › Reconstitution · 25 Sep 2025 · 32 likes I would call the community position on decimal-point error likely rather than established, and I would be comfortable defending that hedge.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #2 · Clinical › Special populations · 19 Sep 2025 · 6 likes On older adults, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #128 · Practice › Reconstitution · 19 Sep 2025 · 2 likes Post #126 and I disagree about the size of the effect, not about the direction. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL…
-
Titles that describe the question, not the situation — what changed since Replied, post #16 · Start Here › How to Ask · 15 Sep 2025 · 0 likes Timeline questions need the timeline. Dates, in order, with what happened on each. "A while ago" and "recently" are the two least useful words in a question of this…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #38 · Data & Tools › Datasets · 7 Sep 2025 · 0 likes Second-hand on Aggregated purity results across four, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
Hypertension improvement and when medication needs revisiting Replied, post #44 · Clinical › Comorbidities · 6 Sep 2025 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #24 · Compounds › Tirzepatide · 27 Aug 2025 · 9 likes Confirming post #21 from a second method, which matters more than confirming it from a second person. On purity: the trailing-edge features people report on tirzepatide…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #107 · Compounds › Semaglutide · 7 Aug 2025 · 8 likes Where the Semaglutide half-life reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Travel coolers and how long they really hold Replied, post #64 · Devices › Cold chain · 6 Aug 2025 · 0 likes Travel coolers looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
How to research a compound with no human data without deceiving yourself Replied, post #61 · Compounds › Other compounds · 2 Aug 2025 · 21 likes The strongest argument against my own position on research a compound, stated as well as I can state it, since nobody else has yet.
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #6 · Practice › Storage & stability · 26 Jul 2025 · 0 likes On post #2 — agreed on the reasoning, with one qualification. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than…
-
Canadian access and provincial variation — one year on Replied, post #4 · Regional › North America · 18 Jul 2025 · 0 likes Appeals succeed more often than people expect when they answer the stated criterion point by point and include nothing else. Scoping that to what I have actually seen…
-
Antibiotics and a course of something with delayed emptying Replied, post #77 · Practice › Interactions · 29 Jun 2025 · 3 likes Counterpoint on antibiotics, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #2 · Analytics › COA interpretation · 28 Jun 2025 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Publishing an inconvenient result: a case study Replied, post #37 · Sourcing › Independent verification · 21 Jun 2025 · 0 likes Worth separating publishing an inconvenient result as a question about the compound from publishing an inconvenient result as a question about the documentation. They…
-
Coming back to: Official shortage notices and what they authorise Replied, post #33 · Access › Shortages · 18 Jun 2025 · 25 likes Planning around a known shortage window is easier than reacting to one, and the notices give advance warning more often than people expect. A modest claim, modestly…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #64 · Compounds › Tirzepatide · 2 Jun 2025 · 3 likes Narrowing post #62, because the general version has more than one answer. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that…
-
Half-life, steady state, and accumulation worked through Replied, post #2 · Pharmacology › Pharmacokinetics · 19 May 2025 · 18 likes Half-life determines how quickly concentration approaches steady state and does not determine what the steady-state concentration is. Dose and clearance determine that.…
-
A page that has drifted out of date and needs a maintainer Replied, post #103 · Documentation › Wiki requests · 14 May 2025 · 0 likes Documents that are mostly a worked example age better than documents that are mostly a summary, because the arithmetic does not change.
-
UK access routes, dated and sourced — a second dataset Replied, post #75 · Regional › UK & Ireland · 9 May 2025 · 8 likes This is the answer, and the reason it is the answer is the more useful part.
-
DXA precision and the least significant change for lean mass — the long version Replied, post #4 · Outcomes › Body composition · 4 May 2025 · 14 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
An emergency department visit, described afterwards Replied, post #15 · Safety › Adverse events · 27 Apr 2025 · 29 likes Post #14 is right about the mechanism and I think understates the practical bit. The most useful contribution to this subcategory is a completed account: what happened,…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #112 · Documentation › Doc review · 18 Apr 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Adjudicated events and why the definition matters — the long version Replied, post #105 · Evidence › Trials · 18 Apr 2025 · 1 like Post #104 answers the question as asked. The question underneath it is different. Absolute and relative effects answer different questions. Write down the event rate in…
-
Adjudicated events and why the definition matters — the long version Replied, post #100 · Evidence › Trials · 15 Apr 2025 · 15 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
-
A report I filed that turned out to be wrong, and the correction Replied, post #14 · Sourcing › Vendor reports · 14 Apr 2025 · 3 likes Post #12 put the caveat in the right place and I want to underline it. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #14 · Analytics › Mass spectrometry · 12 Apr 2025 · 0 likes This follows post #11 rather than contradicting it. Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it…
-
A certificate with no method stated: what can you conclude? Replied, post #52 · Analytics › COA interpretation · 10 Apr 2025 · 0 likes Everything in post #48 holds. The case it does not cover is the one I have. What fields matter on a certificate: lot number matching the vial, test date, the analytical…
-
Review cadence: how often is a page actually re-checked? Replied, post #4 · Documentation › Doc review · 30 Mar 2025 · 0 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything. Anyone with a larger sample, please post it.
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #4 · Compounds › Oral incretins · 8 Mar 2025 · 0 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Validating a method you did not develop — does this still hold? Replied, post #82 · Analytics › Method validation · 7 Mar 2025 · 8 likes That is a fair summary of where the discussion has got to.
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #76 · Evidence › Meta-analyses · 8 Feb 2025 · 0 likes Adding the measurement that post #73 says would settle it. Double extraction with disagreement resolution is standard and is worth checking for, because single…
-
Scheduled maintenance and what will be unavailable Replied, post #35 · Meta › Announcements · 6 Feb 2025 · 0 likes The arithmetic on scheduled maintenance is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch…
-
[2026 update] New subcategory: rationale and scope Replied, post #148 · Meta › Announcements · 14 Jan 2025 · 0 likes I read post #144 twice before replying, because I had assumed the opposite. A definition problem is doing most of the work in this New subcategory discussion. Once the…
-
Gallbladder disease risk with rapid weight loss Replied, post #56 · Clinical › Comorbidities · 12 Jan 2025 · 7 likes Thank you for taking the time. That was more work than a reply usually is.
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #19 · Compounds › Secretagogues & GH axis · 6 Jan 2025 · 9 likes Filing a mild objection to the consensus on well-designed human trial. Mild because I might be wrong; an objection because nobody has addressed the case that does not…
-
Specification in the result column: why that is a meaningful error — the long version Replied, post #6 · Analytics › COA interpretation · 3 Jan 2025 · 0 likes This follows post #5 rather than contradicting it. An itemised related-substances table with retention times says considerably more about the synthesis than a single…
-
Building a sensible monitoring schedule with your prescriber Replied, post #55 · Clinical › Bloodwork · 20 Dec 2024 · 14 likes Adding what did not work for me on building a sensible monitoring schedule, since the failures never get written up and they are half the useful information.
-
What we do not know about retatrutide, listed explicitly Replied, post #22 · Compounds › Retatrutide · 15 Dec 2024 · 7 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Body image changing more slowly than the body Replied, post #33 · Wellbeing › Mental health · 14 Dec 2024 · 19 likes If you are in crisis, contact a local emergency or crisis service rather than posting. A volunteer forum cannot help and waiting costs time.
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #76 · Clinical › Special populations · 26 Nov 2024 · 10 likes Being outside the studied population does not mean a treatment is unsafe. It means the usual evidence is not available and the reasoning has to be explicit.
-
Why "any advice?" is the least effective ending for a post Replied, post #73 · Start Here › How to Ask · 25 Nov 2024 · 6 likes A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
-
Criticising the method without criticising the authors Replied, post #13 · Evidence › Study critique · 26 Oct 2024 · 11 likes My experience of criticising the method without criticising contradicts the reply above. I am posting it as a data point rather than as a refutation, because one…
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #18 · Practice › Interactions · 4 Oct 2024 · 18 likes I read post #14 twice before replying, because I had assumed the opposite. Whatever the answer on Oral contraceptives and delayed emptying turns out to be, the method…
-
Circumference measurements as a poor man's composition estimate Replied, post #60 · Outcomes › Body composition · 12 Aug 2024 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Started this topic · Practice › Dosing & titration · 6 Jul 2024 · 3 likes Posting this under the heading it deserves: Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Everything below is what sits behind…